Quanterix Corporation

Representative image of a laboratory researcher reviewing spatial proteomics data for early-stage breast cancer, reflecting the clinical oncology focus behind the AidaBREAST assay and its potential role in recurrence risk and radiation therapy benefit assessment.

Medical Devices & Diagnostics

Can PreludeDx and Quanterix turn AidaBREAST into a new standard for radiation therapy decisions

by Pallavi Madhiraju
April 18, 2026
0 Comments

See why AidaBREAST could reshape breast cancer radiation decisions and put spatial proteomics closer to routine oncology use.

Read More

Will blood-based Alzheimer’s tests reshape preventive health screening models

Medical Devices & Diagnostics

Lucent Diagnostics expands cognitive biomarker reach through Life Line Screening

by Pallavi Madhiraju
March 3, 2026
0 Comments

Lucent Diagnostics partners with Life Line Screening to expand Alzheimer’s blood testing nationwide. Discover what this means for early detection.

Read More